FDAnews
www.fdanews.com/articles/101416-alnylam-receives-german-patent

Alnylam Receives German Patent

November 26, 2007

The German Patent Office has granted Alnylam Pharmaceuticals a patent for the Kreutzer-Limmer series covering medications comprising small interfering RNAs.

The patent series has been licensed to Alnylam’s four pharmaceutical collaboration partners, the seven biotechnology companies in Alnylam’s InterfeRx program and 15 companies in the research reagent and services market.

Donna Ward, vice president of intellectual property of Alnylam, said the company acquired the RNA interface field in its 2003 merger with Ribopharma.